http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104117064-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104117064-B |
| titleOfInvention | Combined application of isothiocyanate compounds and hormone drugs |
| abstract | The invention relates to combined application of an isothiocyanate compound and a hormone medicine. Specifically, the present invention discloses a composition comprising: (A) a therapeutically effective amount of a first active ingredient which is an isothiocyanate compound or a derivative thereof; (B) a therapeutically effective amount of a second active ingredient, which is a hormone anticancer drug of endocrine therapy, and the mass ratio of the first active ingredient to the second active ingredient is 1-1000: 1000-1. The invention also discloses an active ingredient combination, a medicine box, a medicine composition and application thereof in preparing anti-prostate cancer medicines. The composition, the active ingredient combination and the kit of the invention have excellent effect of inhibiting the growth of prostate cancer cells. |
| priorityDate | 2013-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 317.